Long-acting injectable antiretroviral therapy (LAI-ART) has the potential to transform HIV treatment for adolescents with perinatal HIV infection (APHI). Given the existing knowledge gaps surrounding this recent strategy, we aimed to assess interest in LAI-ART among ART-experienced APHI in Cameroon. We conducted a cross-sectional study among ART-experienced APHI aged 10–19 years, across four paediatric HIV clinics in the Centre region of Cameroon. Data were collected from 4 to 30 November 2024 using structured questionnaires to assess sociodemographic characteristics, awareness of, and interest in LAI-ART. HIV-1 viral load (VL) and CD4 cell counts were measured during the same period. Logistic regression analysis was used to identify factors associated with interest in switching to LAI-ART. Of 248 participants (48.8% female; median [IQR] age 15 [13–17]), 40.0% lived with a guardian and 75.8% had partial/full HIV-disclosure; 3.2% reported stigma. Clinically, 77.5% were in multi-month ARV-dispensation (MDSD) and 28.2% had poor ART-adherence; fear of injection was none/moderate/high in 73.4%, 15.7% and 10.9%, respectively. Viral undetectability (VL<50 copies/mL) and CD4≥500 cells/mm3 were 71.6% and 72.5%, respectively. Overall, 92.3% expressed interest in LAI-ART, motivated by reduced pill burden/fatigue (63.7%) and expected better adherence (74.2%); 30.2% reported prior LAI-ART awareness. In multivariable analysis, no prior awareness had 81% lower odds of interest (p=0.036). Compared with no-fear, moderate-fear was associated with 46% lower odds (p=0.393), while high-fear was associated with 78% lower odds (p=0.017). Disparities in sex, education, residence, adherence, virological response, or treatment history did not influence interest in LAI-ART. Among all respondents, 77.1% said they would choose LAI-ART if available, whereas 20.2% preferred MDSD. In this Cameroonian APHI cohort, awareness of LAI-ART was low despite high-interest once adolescents were informed. Rollout in low/middle-income countries should prioritise targeted education, youth-friendly counselling to close knowledge gaps, reduce fear and ensure equitable uptake.

Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon. Implications for implementation in developing countries / Bouba, Y., Ka'E, A.C., Ayafor, C., Forgwei, L., Gabisa, J.E., Mabongo, D., Nka, A.D., Mejane, R.E., Tetang, S.N., Kamgaing, R.S., Ateba, F.N., Fainguem, N.N., Tchouaket, M.C.T., Takou, D., Kamgaing, N., Menye, M.A., Noukayo, F., Semengue, E.N.J., Basseck, R.W., Wiadamong, A., et al.. - In: PLOS GLOBAL PUBLIC HEALTH. - ISSN 2767-3375. - 6:5(2026), pp. 1-13. [10.1371/journal.pgph.0006293]

Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon. Implications for implementation in developing countries

Mejane, Rita Ekwoge;Russo, Gianluca;D'amelio, Stefano;
2026

Abstract

Long-acting injectable antiretroviral therapy (LAI-ART) has the potential to transform HIV treatment for adolescents with perinatal HIV infection (APHI). Given the existing knowledge gaps surrounding this recent strategy, we aimed to assess interest in LAI-ART among ART-experienced APHI in Cameroon. We conducted a cross-sectional study among ART-experienced APHI aged 10–19 years, across four paediatric HIV clinics in the Centre region of Cameroon. Data were collected from 4 to 30 November 2024 using structured questionnaires to assess sociodemographic characteristics, awareness of, and interest in LAI-ART. HIV-1 viral load (VL) and CD4 cell counts were measured during the same period. Logistic regression analysis was used to identify factors associated with interest in switching to LAI-ART. Of 248 participants (48.8% female; median [IQR] age 15 [13–17]), 40.0% lived with a guardian and 75.8% had partial/full HIV-disclosure; 3.2% reported stigma. Clinically, 77.5% were in multi-month ARV-dispensation (MDSD) and 28.2% had poor ART-adherence; fear of injection was none/moderate/high in 73.4%, 15.7% and 10.9%, respectively. Viral undetectability (VL<50 copies/mL) and CD4≥500 cells/mm3 were 71.6% and 72.5%, respectively. Overall, 92.3% expressed interest in LAI-ART, motivated by reduced pill burden/fatigue (63.7%) and expected better adherence (74.2%); 30.2% reported prior LAI-ART awareness. In multivariable analysis, no prior awareness had 81% lower odds of interest (p=0.036). Compared with no-fear, moderate-fear was associated with 46% lower odds (p=0.393), while high-fear was associated with 78% lower odds (p=0.017). Disparities in sex, education, residence, adherence, virological response, or treatment history did not influence interest in LAI-ART. Among all respondents, 77.1% said they would choose LAI-ART if available, whereas 20.2% preferred MDSD. In this Cameroonian APHI cohort, awareness of LAI-ART was low despite high-interest once adolescents were informed. Rollout in low/middle-income countries should prioritise targeted education, youth-friendly counselling to close knowledge gaps, reduce fear and ensure equitable uptake.
2026
hiv; art; long-acting; cameroon; adolescent
01 Pubblicazione su rivista::01a Articolo in rivista
Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon. Implications for implementation in developing countries / Bouba, Y., Ka'E, A.C., Ayafor, C., Forgwei, L., Gabisa, J.E., Mabongo, D., Nka, A.D., Mejane, R.E., Tetang, S.N., Kamgaing, R.S., Ateba, F.N., Fainguem, N.N., Tchouaket, M.C.T., Takou, D., Kamgaing, N., Menye, M.A., Noukayo, F., Semengue, E.N.J., Basseck, R.W., Wiadamong, A., et al.. - In: PLOS GLOBAL PUBLIC HEALTH. - ISSN 2767-3375. - 6:5(2026), pp. 1-13. [10.1371/journal.pgph.0006293]
File allegati a questo prodotto
File Dimensione Formato  
Bouba_Interest_2026.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 730.63 kB
Formato Adobe PDF
730.63 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1770940
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact